MARKET

MANE

MANE

VERADERMICS INC
NYSE
112.71
+1.71
+1.54%
After Hours: 112.00 -0.71 -0.63% 19:34 08/14 EDT
OPEN
110.28
PREV CLOSE
111.00
HIGH
113.52
LOW
109.84
VOLUME
523.47K
TURNOVER
--
52 WEEK HIGH
131.24
52 WEEK LOW
32.00
MARKET CAP
4.71B
P/E (TTM)
-33.6398
1D
5D
1M
3M
1Y
5Y
1D
We Think Veradermics (NYSE:MANE) Can Afford To Drive Business Growth
Simply Wall St · 1d ago
Citi Sticks to Its Buy Rating for Veradermics, Incorporated (MANE)
TipRanks · 2d ago
Buy Rating Reaffirmed on Strong VDPHL01 Data and Catalyst-Rich Roadmap; Price Target Maintained at $164
TipRanks · 3d ago
Veradermics Q2 EPS $(0.58) Beats $(0.65) Estimate
Benzinga · 4d ago
Veradermics: Q2 Earnings Snapshot
Barchart · 4d ago
Analysts Are Bullish on Top NA Stocks: Veradermics, Incorporated (MANE), Bicara Therapeutics Inc. (BCAX)
TipRanks · 4d ago
Veradermics sees cash runway into 2030
TipRanks · 4d ago
Veradermics reports Q2 net loss ($23.5M) vs. ($15.6M) last year
TipRanks · 4d ago
More
About MANE
Veradermics, Incorporated is a late clinical-stage biopharmaceutical company. The Company is focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Its initial focus is developing better treatments for pattern hair loss (PHL). The Company is developing VDPHL01 as an oral, non-hormonal treatment for men and women with PHL to reduce the barriers to wide adoption of chronic hair loss therapy and potentially transform PHL treatment. VDPHL01 is an oral, ER formulation of minoxidil, a proven hair growth agent, designed to maximize minoxidil’s impact on hair restoration while minimizing the risk of cardiac activity. The Company is conducting a Phase II clinical trial evaluating VDPHL01 in male and female patients with mild-to-moderate PHL.

Webull offers Veradermics Inc stock information, including NYSE: MANE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MANE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MANE stock methods without spending real money on the virtual paper trading platform.